MENU ABOUT US MAKE A DONATION
The Epoch Times
Login
SEARCH
CLOSE
Help Center subscribe newsletter Newsstands Epoch Shop Gift
  • TOP NEWS
  • SPECIAL SERIES
  • SPECIAL COVERAGE
  • LATEST ARTICLES
  • US
    • US News
    • US Features
    • US Politics
    • US Crime News
    • New York
    • San Francisco
    • Los Angeles
  • Opinion
    • Thinking About China
    • Viewpoints
    • Unbridled Evil: The Corrupt Reign of Jiang Zemin in China
    • The Reader’s Turn
  • China News
    • US-China Relations
    • Chinese Regime
    • Business & Economy
    • Chinese Culture
    • China Human Rights
    • Social Issues
    • Organ Harvesting in China
  • World News
    • Africa News
    • Americas
    • Asia & Pacific
    • Canada
    • Europe
    • UK News
    • Australia News
    • International
    • Middle East
  • Business & Markets
    • Companies
    • Economy
    • Markets
    • Real Estate
    • Gold and Commodities
  • ARTS & CULTURE
    • Fine Arts & Craftsmanship
    • Performing Arts
    • Books
    • Traditional Culture
    • Shen Yun Special Coverage
    • Film & TV
  • Science
    • News
    • Space
    • Environment
  • Tech
    • Tech News
    • Tech Products & Reviews
    • Social Media
  • Sports
  • Videos
    • American Thought Leaders
    • China Insider
    • Crossroads
  • Bright
    • Lifestyle
    • Inspired
    • Family & Education
    • Personal Finance
    • American Essence
  • Entertainment
    • Film & TV
    • Entertainment News
  • Health
    • Experts
    • Conditions
    • Life & Wellness
  • Special Topics
    • Battlefields
SEARCH
  • EpochTV
  • US
  • US Politics
  • Opinion
  • World News
  • China
  • Hong Kong
  • Health
  • Bright
  • Arts
  • Falun Gong
  • Premium
  • Markets
  • Games
  • Livestream
  • More

Martin Shkreli

  • US Judge Bars Martin Shkreli From Drug Industry, Orders $64.6 Million Payment
    US Judge Bars Martin Shkreli From Drug Industry, Orders $64.6 Million Payment
    WASHINGTON—A U.S. judge on Friday barred Martin Shkreli from the pharmaceutical industry for life and ordered him to pay $64.6 million after he famously raised the price of the drug ...
    January 16, 2022BY Reuters
  • NTD News Today Full Broadcast (Dec. 15)
    NTD News Today Full Broadcast (Dec. 15)
    Communities in Kentucky are helping each other survive the tornado aftermath and mourning those they've lost, Amtrak is suspending ...
    December 15, 2021BY NTD Television
  • FTC and Several States to Recoup Funds for Victims of Price Gouging Scheme by Martin Shkreli
    FTC and Several States to Recoup Funds for Victims of Price Gouging Scheme by Martin Shkreli
    The Federal Trade Commission (FTC) and the states of New York, California, Illinois, North Carolina, Ohio, Pennsylvania, and Virginia are ...
    December 8, 2021BY Katabella Roberts
  • Supreme Court Rejects ‘Pharma Bro’ Shkreli’s Appeal of Fraud Conviction
    Supreme Court Rejects ‘Pharma Bro’ Shkreli’s Appeal of Fraud Conviction
    The U.S. Supreme Court has refused to take up the appeal case of Martin Shkreli, the disgraced former pharmaceutical ...
    November 18, 2019BY Janita Kan
  • Martin Shkreli Admits to Faking Donald Trump Endorsement on Live Stream
    Martin Shkreli Admits to Faking Donald Trump Endorsement on Live Stream
    Shkreli then added: "I don't like Trump, I'm just [expletive] kidding. He's an idiot. Just trying to get ...
    May 27, 2016BY Andrew Simontacchi
  • 50 Cent Donates $100k to Autism Speaks After Viral Airport Incident, Reports Say
    50 Cent Donates $100k to Autism Speaks After Viral Airport Incident, Reports Say
    The hip-hop artist donated $100,000 to Autism Speaks after posting (and since taking down), a video to Instagram ...
    May 5, 2016BY Andrew Simontacchi
  • Martin Shkreli: New Charges Possible for Embattled Drug Company Founder
    Martin Shkreli: New Charges Possible for Embattled Drug Company Founder
    Martin Shkreli, the drug company founder charged with defrauding investors, may face additional charges.
    May 3, 2016BY Petr Svab
  • Feds: Witnesses Fear Retaliation From Ex-pharma CEO Martin Shkreli
    Feds: Witnesses Fear Retaliation From Ex-pharma CEO Martin Shkreli
    Several witnesses in a securities fraud case against pharmaceutical executive Martin Shkreli are concerned he will retaliate if ...
    February 20, 2016BY The Associated Press
  • Drug Price-Hiking: Congress Unites in Scorn for Martin Shkreli, but Gridlock Remains
    Drug Price-Hiking: Congress Unites in Scorn for Martin Shkreli, but Gridlock Remains
    A smirking Martin Shkreli briefly united Democrats and Republicans on Capitol Hill this week, as lawmakers took turns ...
    February 7, 2016BY The Associated Press
  • Congress: Drugmakers Planned Price Hikes to Boost Profits
    Congress: Drugmakers Planned Price Hikes to Boost Profits
    Two drugmakers have made a practice of buying and then dramatically hiking the prices of low-cost drugs given ...
    February 2, 2016BY The Associated Press
  • Price-Hiking Pharma Exec Martin Shkreli Gets House Subpoena
    Price-Hiking Pharma Exec Martin Shkreli Gets House Subpoena
    WASHINGTON—House lawmakers have issued a subpoena to compel former Turing Pharmaceuticals CEO Martin Shkreli, reviled for price-gouging, to ...
    January 20, 2016BY The Associated Press
  • KaloBios, Formerly Led by Martin Shkreli, Files for Bankruptcy
    KaloBios, Formerly Led by Martin Shkreli, Files for Bankruptcy
    KaloBios, the troubled drugmaker taken over by Martin Shkreli last month, is seeking bankruptcy protection less than two ...
    December 30, 2015BY The Associated Press
  • Controversial Pharma Executive Arrested Over Fraud Charges
    Controversial Pharma Executive Arrested Over Fraud Charges
    A boyish-looking entrepreneur who became the new face of corporate greed when he jacked up the price of ...
    December 17, 2015BY The Associated Press
  • Turing CEO Martin Shkreli in Custody After Securities Probe
    Turing CEO Martin Shkreli in Custody After Securities Probe
    Martin Shkreli, the former hedge fund manager under fire for buying a pharmaceutical company and ratcheting up the ...
    December 17, 2015BY The Associated Press
  • Senate Panel Summons Price-Hiking CEO of Turing Pharma
    Senate Panel Summons Price-Hiking CEO of Turing Pharma
    A Senate committee has launched an investigation into exorbitant drug price hikes by Turing Pharmaceuticals and three other ...
    November 4, 2015BY The Associated Press
TOP NEWS
  • Tanker Collides With Docked Riverboat in New Orleans
    NEW By Jacki Thrapp
    Tanker Collides With Docked Riverboat in New Orleans
  • FAA Issues Emergency Ground Stop for All US Flights for ‘Extraordinary Circumstances’
    2hr By Jill McLaughlin
    FAA Issues Emergency Ground Stop for All US Flights for ‘Extraordinary Circumstances’
  • Supreme Court Takes Up Robinhood Investor Lawsuit
    3hr By Stacy Robinson
    Supreme Court Takes Up Robinhood Investor Lawsuit
  • Supreme Court to Consider Trump’s Asylum Restrictions at Southern Border
    3hr By Jack Phillips
    Supreme Court to Consider Trump’s Asylum Restrictions at Southern Border
  • Cisco Sued in California Over Alleged Link to Human Rights Abuses
    3hr By Eva Fu
    Cisco Sued in California Over Alleged Link to Human Rights Abuses
  • DOJ Says Agencies Should Prioritize English Over Other Languages
    5hr By Jack Phillips
    DOJ Says Agencies Should Prioritize English Over Other Languages
  • Kremlin Says Europe Must Show Readiness to Contribute to Peace Process Before Joining Talks
    5hr By Victoria Friedman
    Kremlin Says Europe Must Show Readiness to Contribute to Peace Process Before Joining Talks
  • New White House Chief of Staff Imposes Restrictions on Meeting With Lobbyists
    7hr By Zachary Stieber
    New White House Chief of Staff Imposes Restrictions on Meeting With Lobbyists
  • Microsoft Outlook Emails Approaching Normal Levels After Outage, Company Says
    7hr By Jack Phillips
    Microsoft Outlook Emails Approaching Normal Levels After Outage, Company Says
  • Trump-Ordered Vaccine Safety Report Delayed Past Deadline
    7hr By Zachary Stieber
    Trump-Ordered Vaccine Safety Report Delayed Past Deadline
The Epoch Times
Copyright © 2000 - 2026 The Epoch Times Association Inc. All Rights Reserved.
Back Top